Detalhe da pesquisa
1.
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients.
Cell
; 184(7): 1821-1835.e16, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33667349
2.
Autochthonous Dengue Fever in 2 Patients, Rome, Italy.
Emerg Infect Dis
; 30(1): 183-184, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37967518
3.
Molnupiravir increases SARS-CoV-2 genome diversity and complexity: A case-control cohort study.
J Med Virol
; 96(5): e29642, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38708812
4.
A case of severe Plasmodium ovale malaria with acute respiratory distress syndrome and splenic infarction in a male traveller presenting in Italy.
Malar J
; 23(1): 93, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38575935
5.
A machine learning approach for early identification of patients with severe imported malaria.
Malar J
; 23(1): 46, 2024 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38351021
6.
Transitions of blood immune endotypes and improved outcome by anakinra in COVID-19 pneumonia: an analysis of the SAVE-MORE randomized controlled trial.
Crit Care
; 28(1): 73, 2024 03 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38475786
7.
Compassionate Use of Remdesivir for Patients with Severe Covid-19.
N Engl J Med
; 382(24): 2327-2336, 2020 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32275812
8.
Profiling the acute phase antibody response against mpox virus in patients infected during the 2022 outbreak.
J Med Virol
; 95(6): e28851, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37287343
9.
Effect of tecovirimat on healing time and viral clearance by emulation of a target trial in patients hospitalized for mpox.
J Med Virol
; 95(6): e28868, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37306318
10.
Temporal intra-host variability of mpox virus genomes in multiple body tissues.
J Med Virol
; 95(5): e28791, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37226579
11.
Viral load decrease in SARS-CoV-2 BA.1 and BA.2 Omicron sublineages infection after treatment with monoclonal antibodies and direct antiviral agents.
J Med Virol
; 95(1): e28186, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36184918
12.
Evolution of SARS-CoV-2 variants of concern over a period of Delta and Omicron cocirculation, among patients hospitalized for COVID-19 in an Italian reference hospital: Impact on clinical outcomes.
J Med Virol
; 95(6): e28831, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37246793
13.
Interferon gamma-induced protein 10 (IP-10) for the early prognosis of the risk for severe respiratory failure and death in COVID-19 pneumonia.
Cytokine
; 162: 156111, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36529030
14.
Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies.
J Neurol Neurosurg Psychiatry
; 94(4): 290-299, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36522154
15.
Management of patients with lymphoma and COVID-19: Narrative review and evidence-based practical recommendations.
Hematol Oncol
; 41(1): 3-15, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36251481
16.
Dual combined antiviral treatment with remdesivir and nirmatrelvir/ritonavir in patients with impaired humoral immunity and persistent SARS-CoV-2 infection.
Hematol Oncol
; 41(5): 904-911, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37452579
17.
Efficacy and safety of therapies for COVID-19 in pregnancy: a systematic review and meta-analysis.
BMC Infect Dis
; 23(1): 776, 2023 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37946100
18.
Outbreaks of autochthonous Dengue in Lazio region, Italy, August to September 2023: preliminary investigation.
Euro Surveill
; 28(44)2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37917030
19.
Comparison of SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples from Patients Infected with Omicron Variant.
Int J Mol Sci
; 24(5)2023 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36902277
20.
Dynamic Evolution of Humoral and T-Cell Specific Immune Response to COVID-19 mRNA Vaccine in Patients with Multiple Sclerosis Followed until the Booster Dose.
Int J Mol Sci
; 24(10)2023 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37239872